Company intelligence / Profile preview

Voxeleron

Austin, Texas, United Statesvoxeleron.com ↗

Ownership: Private
Development stage: Commercial

Overview

Voxeleron's Orion platform has demonstrated higher accuracy and reduced variability in optical coherence tomography (OCT) image analysis compared to original equipment manufacturer software, supporting more reliable endpoints in ophthalmic clinical trials. The company’s solutions are widely adopted by CROs, reading centers, sponsors, and sites to accelerate recruitment and improve outcomes in eye disease research. No direct therapeutic or drug development results as the company provides enabling technology.

Therapeutic areas: Ophthalmology
Modalities: Software platformAI/ML-based image analysis
Industry: Digital Health Medical Devices

Partnerships

Lexitas Pharma ServicesWorld Care ClinicalVoiant (post-acquisition)

Beyond the preview

Go deeper on Voxeleron.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voxeleron.

Explore the full profile